- Microsoft CEO Pours Cold Water on Yahoo Interest
- DBS Profit Dips 38%; Bank Warns About Outlook
- South Korea Cuts Rates For Third Time In a Month
- Toyota Dives as Trade Resumes After Profit Warning
- Panasonic Shares Plunge on Sanyo Electric Deal
- Asian Stocks Turn Mixed, KOSPI Rebounds After Rate Cut
- Qualcomm Shares Fall on Weaker Outlook
- Fed Balance Sheet Tops $2 trillion for First Time
- Disney Misses Estimates as Theme Parks Suffer
- Lightning Round: Intel, ABB, Goldman Sachs and More
- Lightning Round OT: Quanta Services, Jacobs Engineering and More
- Sell Block: The Problem With Analysts
- Executive Decision: Tupperware CEO Rick Goings
- Buffett's Buying, But Should You?
- Your First Move For Friday November 7th
- Web Extra: Battle The Bear
- Fast & Furious Trades For Friday
- Biggest 2 Day Decline Since '87
- India car sales hit by global financial crisis
- Uncertain changes ahead for Calif. egg industry
- British Airways loses 49 million pounds in 1H
- Microsoft CEO: No interest in buying Yahoo
- 5 SE Asian nations meet to boost cooperation
- Daiichi completes takeover of India's Ranbaxy Labs
- Singapore DBS cuts 900 jobs, 6 percent of workers
- Honda shows wearable device that helps you walk
- Lenovo says profit down 78 percent on weaker sales
- Report: HK investors sue banks over Lehman product
BEIJING - China's drug safety watchdog said Thursday it has stopped all production at a company in northeastern China after an herbal injection it sold was suspected of causing the deaths of three people.
The State Food and Drug Administration said Wandashan Pharmaceutical Co. in Heilongjiang province made the herbal injection suspected of causing the deaths last month. The company had already voluntarily recalled all of its injectable products.
"This is a serious incident caused by drug contamination," spokeswoman Yan Jiangying told a news conference, according to a transcript posted on the administration's Web site.
The move comes as China is trying to reassure consumers over a scandal involving the spread of the industrial chemical melamine into the food chain, the latest to mar its already troubled product safety record.
Yan said the herbal injection, called ciwujia, was soaked by rain while in storage and contaminated by bacteria.
She said the contaminated products were then sold after being put in new packaging.
"The company's action seriously violated the drug management law and it should be punished for producing the drug," Yan said.
China's pharmaceutical industry is highly lucrative but poorly regulated, resulting in some companies using fake or substandard ingredients. In recent years, a string of fatalities blamed on counterfeit or shoddily made medications has been reported.
Last month, the official Xinhua News Agency said health authorities ordered hospitals to stop using another herbal drug suspected of causing the death of a newborn and triggering "adverse effects" in three others.


